Norethindrone

• Birth Control
• Endometriosis
• Abnormal Uterine Bleeding
• Secondary Amenorrhea

Norethindrone is a synthetic progestin used as a progestin-only oral contraceptive (often called the mini-pill) and, in higher-dose forms, for endometriosis, abnormal uterine bleeding, and secondary amenorrhea. Brand names include Camila, Errin, Heather, and Aygestin. Because it does not contain estrogen, the mini-pill remains an option for women who are breastfeeding, who have a history of venous thromboembolism, who suffer migraine with aura, or who otherwise cannot take combined hormonal contraception. The trade-off is that it requires strict timing and produces less predictable bleeding than estrogen-containing pills, but for the right patient it is a safe and reliable option.

Mechanism of Action

Norethindrone is a 19-nortestosterone derivative that binds progesterone receptors in the reproductive tract and central nervous system. At the low contraceptive dose of 0.35 mg daily it relies primarily on cervical and endometrial effects rather than full ovulation suppression. Cervical mucus becomes thick and hostile to sperm penetration within four hours of ingestion and remains hostile for roughly 22 hours, which is why dosing must be reliable to within a three-hour window. Endometrial tissue undergoes a glandular and stromal transformation that becomes inhospitable to implantation. Fallopian tube motility slows. Ovulation is suppressed in roughly half of cycles at the contraceptive dose, more reliably at therapeutic doses.

At the higher doses used for menstrual disorders and endometriosis, norethindrone acetate provides full progestational effect on endometrial tissue. It opposes estrogen-driven endometrial proliferation, converting a proliferative lining to a secretory phase, then producing decidual atrophy with sustained use. In endometriosis this means atrophy of ectopic endometrial implants and reduction in pelvic pain over months of therapy. The molecule also has mild androgenic activity, which can occasionally produce acne or oily skin in susceptible women but generally does not cause hirsutism at standard doses. Norethindrone is rapidly absorbed orally, reaches peak concentration within one to two hours, and has a half-life of about 8 hours, which underpins its narrow once-daily timing window in contraceptive use. The hepatic metabolism involves CYP3A4 among other pathways, which becomes relevant when strong inducers are coprescribed. Background information on contraceptive options is available from the CDC.

Clinical Use

Within contraceptive choices the mini-pill sits below combined oral contraceptives, the patch, and the ring in everyday effectiveness because of its narrow timing window, but it is the safest oral option for women who must avoid estrogen. Common scenarios include the postpartum and breastfeeding periods, women over 35 who smoke, women with a history of deep vein thrombosis or pulmonary embolism, and women with migraine with aura. It is also a reasonable bridge while a long-acting reversible contraceptive such as an IUD or implant is being arranged. Comparative real-world failure rates run around 9 percent typical use, similar to combined pills, with perfect-use rates closer to 0.3 percent.

For abnormal uterine bleeding, norethindrone acetate at 5 to 10 mg daily can stop an active bleeding episode and stabilize the endometrium, sometimes used as a luteal phase complement to estrogen or in cyclic regimens. For endometriosis, continuous higher-dose norethindrone acetate produces amenorrhea in many patients and reduces dysmenorrhea, often as an alternative to GnRH agonists with fewer hypoestrogenic effects. Patient selection considers smoking status, cardiovascular risk, breast cancer history, and prior tolerance of progestins. Comparative options include levonorgestrel-ethinyl estradiol when estrogen is acceptable, etonogestrel implant for long-acting reversible contraception, and the levonorgestrel intrauterine system for combined contraception and bleeding control. The newer drospirenone-only pill offers a 24-hour rather than 3-hour window but at higher cost. Patients can read about contraceptive choice at MedlinePlus. Decision-making is highly individualized and benefits from open conversation about life circumstances, future fertility plans, and tolerance of irregular bleeding.

How to Take It

The progestin-only contraceptive must be taken once daily at the same time every day, with no placebo week and no breaks. The dosing window is three hours; if a dose is more than three hours late, take the missed pill as soon as possible, take the next one at the regular time, and use a backup method of contraception for the next 48 hours. If vomiting occurs within two hours of a dose, take another pill immediately. Doses should be set to a consistent daily reminder; an alarm tied to a regular routine such as a meal helps adherence. Tablets are stored at room temperature, away from moisture. The first three months commonly bring irregular spotting, lighter periods, or temporary amenorrhea; this generally improves but may persist. Counseling at the first visit about realistic bleeding expectations greatly increases continuation rates. Patients traveling across time zones should consider whether the three-hour window allows easy adjustment to local time, and may need to consult on transition strategy. Those with chronic gastrointestinal disease or recent bariatric surgery may have absorption variability that compromises efficacy.

For higher-dose therapeutic regimens, the prescribed schedule is followed without skipping, and missed doses are taken as soon as remembered unless it is close to the next dose.

Monitoring and Follow-Up

Baseline evaluation includes blood pressure, weight, a focused gynecologic and bleeding history, and screening for contraindications such as breast cancer history, undiagnosed bleeding, severe liver disease, or current thromboembolic disease. Routine cervical cancer screening continues at age-appropriate intervals. Follow-up at three months reviews adherence, side effects, and bleeding patterns; many patients do not require labs unless a clinical concern arises. Annual visits track blood pressure, weight, and any new medical issues. Numbers and symptoms worth attention include sudden severe abdominal pain that may suggest ectopic pregnancy in the rare instance of method failure, jaundice or right upper quadrant pain that may signal liver involvement, persistent severe headaches, calf swelling, or shortness of breath. Pregnancy testing is appropriate for any missed period beyond two weeks if pills have not been perfectly timed, since pregnancy on the mini-pill is more likely to be ectopic than with combined pills. For higher-dose endometriosis use, a follow-up at three months assesses pain reduction and any progestin side effects such as mood changes or weight gain. Bone density may decline with prolonged amenorrhea-inducing doses; clinicians sometimes consider DEXA scans after extended therapy beyond two years, particularly in younger patients.

Special Populations

The progestin-only pill is the preferred oral contraceptive during breastfeeding because it does not affect milk supply and is safe for the nursing infant. Adolescents past menarche may use it safely. Older perimenopausal women can continue it through the transition. Severe hepatic impairment is a contraindication. In renal disease no specific dose adjustment is needed, but caution is reasonable. It is contraindicated in current breast cancer, undiagnosed abnormal uterine bleeding, active liver tumors, and known or suspected pregnancy. Women with a history of bariatric surgery, particularly malabsorptive procedures, may have reduced absorption and should consider a non-oral method. Drug interactions of greatest concern are with strong CYP3A4 inducers including rifampin, certain antiseizure medications such as phenytoin and carbamazepine, and St. John's wort, which can reduce contraceptive efficacy and may require an alternative method. Most antibiotics, contrary to common belief, do not reduce norethindrone effectiveness. Women on antiretroviral therapy require careful review of specific agents because some boost and some reduce progestin levels. Women with a history of severe depression should be monitored after initiation because mood worsening occurs in a minority of patients.

When to Contact Your Doctor

Call promptly for sudden severe abdominal or pelvic pain that could indicate ectopic pregnancy, especially if a period is missed and pills have not been perfectly timed. Severe headache, vision changes, slurred speech, or one-sided weakness require emergency evaluation. Calf pain or swelling, chest pain, or shortness of breath may indicate clot. Yellowing of the skin or eyes, dark urine, or persistent right upper quadrant pain suggest liver problems. Heavy or prolonged bleeding, a new breast lump, or signs of pregnancy such as missed period with breast tenderness should be reported. Persistent depression, mood changes, or worsening migraine pattern also warrant a conversation. New or worsening acne, hair changes, or unexplained weight gain may benefit from a medication review.

If you would like to discuss whether the progestin-only pill or a different contraceptive option fits your needs, contact us or schedule a visit with our St. Petersburg internal medicine team for personalized counseling.